Dornase alfa 1 mg/ML Inhalation Solution
RxNorm 310014
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 310014 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: dornase alfa 1 mg/ML Inhalation Solution.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Dornase alfa 1 mg/ML Inhalation Solution
(Atom ID: 12343836)
PSNPrescribable
Prescribable Name (PSN):
Dornase alfa 1 mg/ML Inhalation Solution
(Atom ID: 10788522)
PTGBPrescribable
British preferred term (PTGB):
Dornase alfa 1 mg/mL solution for nebuliser
(Atom ID: 12820999)
PTPrescribable
Designated preferred name (PT):
Dornase alfa 1 mg/mL solution for nebulizer
(Atom ID: 12821000)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely dornase alfa 1 mg/1 mL conventional release solution for nebulizer (clinical drug)
(Atom ID: 12821540)
Patient Education
Dornase Alfa
Dornase alfa is used to reduce the number of lung infections and to improve lung function in patients with cystic fibrosis. It breaks down the thick secretions in the airways, allowing air to flow better and preventing bacteria from building up. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
[Learn More]
* Please review the disclaimer below.